| TIZIANA LIFE SCIENCES LTD |
| Hong Kong (China) |
| Gesundheit |
| BMG889121031 / A3C5SS |
| 0RP (Frankfurt) / TLSA (NASDAQ) |
| FRA:0RP, ETR:0RP, 0RP:GR, NASDAQ:TLSA |
| - |
| https://www.tizianalifesc.. |
|
Tiziana Life Sciences Ltd. is a biotechnology company primarily engaged in the research and development of novel therapeutics for cancer, inflammatory diseases, and immune-related conditions. As part of the biotech sector, its operations focus on lev..
>Volltext.. |
| 151.6 Mio. EUR |
| 148.57 Mio. EUR |
| - |
| -18.14 Mio. EUR |
| -15.89 Mio. EUR |
| -0.13 EUR |
| 0.39 Mio. EUR |
| 3.46 Mio. EUR |
| - |
| 0.36 |
| - |
| -36.94% |
| - |
| - |
| - |
| - |
| TIZIANA |
| 24.05.26 |
|